Page last updated: 2024-10-30

mefenamic acid and Liver Cirrhosis

mefenamic acid has been researched along with Liver Cirrhosis in 1 studies

Mefenamic Acid: A non-steroidal anti-inflammatory agent with analgesic, anti-inflammatory, and antipyretic properties. It is an inhibitor of cyclooxygenase.
mefenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,3-dimethylphenyl group. Although classed as a non-steroidal anti-inflammatory drug, its anti-inflammatory properties are considered to be minor. It is used to relieve mild to moderate pain, including headaches, dental pain, osteoarthritis and rheumatoid arthritis.

Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tkaczewski, W1
Adamska-Dyniewska, H1
Gajewska, B1
Kowalczyk, L1

Other Studies

1 other study available for mefenamic acid and Liver Cirrhosis

ArticleYear
[Pharmacokinetics of mefenamic acid in patients with liver cirrhosis].
    Polski tygodnik lekarski (Warsaw, Poland : 1960), 1978, Dec-25, Volume: 33, Issue:52

    Topics: Adult; Humans; Kinetics; Liver; Liver Cirrhosis; Mefenamic Acid; Middle Aged

1978